Skip to main content
NUTRITIONAL GROWTH SOLUTIONS LTD logo

NUTRITIONAL GROWTH SOLUTIONS LTD — Investor Relations & Filings

Ticker · NGS ISIN · IL0011681116 ASX Manufacturing
Filings indexed 356 across all filing types
Latest filing 2023-12-13 Regulatory Filings
Country AU Australia
Listing ASX NGS

About NUTRITIONAL GROWTH SOLUTIONS LTD

https://ngsolutions.co/

Nutritional Growth Solutions Ltd. specializes in the development and commercialization of clinically-proven nutritional supplements designed to support the growth and development of children. The company’s core product portfolio, marketed under the Healthy Heights brand, features protein shakes and nutritional powders formulated with a specific balance of macronutrients and micronutrients. These formulations are based on extensive clinical research conducted at the Schneider Children’s Medical Center and are intended for children who are short or lean. The company focuses on providing scientifically validated solutions to address nutritional gaps and promote healthy physical development. Its unique value proposition is centered on peer-reviewed clinical studies demonstrating the efficacy of its products in increasing height and weight without adversely affecting body mass index.

Recent filings

Filing Released Lang Actions
Becoming a substantial holder - Balmain Resouces 4 pages 85.4KB
Regulatory Filings
2023-12-13 English
Cessation of Listed Options 9 pages 433.5KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 23 November 2023 regarding the cessation of listed options for Nutritional Growth Solutions Ltd. It includes an Appendix 3H form, which is a regulatory form used to notify the Australian Securities Exchange (ASX) of the cessation of securities, specifically options that have expired without exercise or conversion. The document is a formal notification of cessation of securities, not a financial report, earnings release, or management discussion. It is regulatory in nature and fits the category of a regulatory announcement about securities cessation. The presence of the Appendix 3H form and the nature of the content align with Regulatory Filings (RNS) rather than a financial report or other categories.
2023-11-22 English
Investor Webinar 2 pages 160.2KB
Investor Presentation Classification · 90% confidence The document is an ASX announcement dated 20 November 2023 inviting shareholders and investors to attend an upcoming investor webinar hosted by the CEO. It provides details about the event, registration link, and contact information. There is no financial data, no report attached or referenced as being published, and no regulatory filings or certifications. The content is clearly an invitation to an investor presentation event rather than the presentation itself or a financial report. Therefore, the document best fits the category of an Investor Presentation announcement or invitation.
2023-11-19 English
Quarterly Activities/Appendix 4C Cash Flow Report 15 pages 879.1KB
Interim / Quarterly Report Classification · 95% confidence The document is an ASX announcement dated 31 October 2023, titled 'Quarterly Activities Report for the Period Ended 30 September 2023'. It provides detailed operational and financial highlights for the quarter, including cash receipts, sales growth, product launches, and strategic updates. The content focuses on quarterly business activities and financial performance for a period shorter than a full fiscal year. It contains substantive financial data and analysis, such as cash flow status, sales velocity, and cost reductions. This matches the definition of an Interim / Quarterly Report (IR). The document is lengthy (15,000 characters) and contains actual financial and operational data, so it is not merely an announcement or a certification. Therefore, the correct classification is IR with high confidence. Q3 2023
2023-10-30 English
Listed Options Expiry 1 page 162.8KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 27 October regarding the expiry of listed options (ASX: NGSO) with an exercise price of $0.27, scheduled to expire on 19 November 2023. It provides details about the option exercise price, expiry date, cessation of trading, and compliance with ASX appendix 6A 5.3 regarding notices to option holders. The document is short (2454 characters) and is an announcement about a capital market instrument (options) expiry, not a financial report or detailed financial data. It does not contain financial statements or management discussion. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit other specific categories like Capital/Financing Update or Share Issue/Capital Change, since it is about option expiry notification rather than new capital issuance or financing activity.
2023-10-26 English
NGS Business Operations Unaffected by Israel Conflict 2 pages 180.2KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 23 October 2023 providing an update on the company's business operations and distribution channels, specifically stating that operations are unaffected by the Israel conflict. It discusses strategic growth plans and sales channels but does not contain financial statements, detailed financial results, or regulatory filings. The document is relatively short (4126 characters) and serves as a business update rather than a financial report or regulatory filing. It does not announce voting results, management changes, or capital structure changes. Therefore, it fits best as a general regulatory announcement about business operations and strategy, which aligns with the Regulatory Filings (RNS) category as a fallback for miscellaneous announcements that do not fit other categories.
2023-10-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.